AliveCor

AliveCor aims to provide medical professionals, patients, and consumers worldwide with mobile-powered devices, data, and analysis to identify, prevent, and manage life-altering diseases from anywhere in the world. As a first offering, AliveCor has developed a clinical-quality, low-cost mobile ECG device, which enables patients to monitor their heart health anywhere, at any time, and provides physicians with an additional heart health assessment tool. AliveCor’s mobile ECG device is designed to work in conjunction with a variety of mobile platforms, including iPhone, iPad, and Android devices.

AliveCor product

AliveCor experimental AI found to compare favorably to an ILR

This is significant considering that ILRs have been viewed as the industry gold standard, allowing for long-term surveillance of AFib.
iPhone Six Lead EKG

AliveCor’s 6-lead ECG reader coming soon

More leads mean increased accuracy, which could potentially mean more lives saved.
AliveCor KardiaMobile

AliveCor’s bloodless hyperkalemia test scores the “Breakthrough Device” designation from the FDA

This means that the agency will consider AliveCor's technology on an accelerated clearance track.
AliveCor Kardia Band

AliveCor launches Kardia Band, the first FDA-cleared medical accessory for Apple Watch

The company has also introduced the SmartRhythm feature that continuously monitors heart rate from the Apple Watch.
Kardia Mobile with Phone

AliveCor, Mayo Clinic to use AI to help prevent sudden cardiac death

The two parties have teamed-up to develop tools for medical and non-medical personnel to easily screen for congenital long QT syndrome (LQTS) early.
AliveCor fingers Kardia - iPhone

AliveCor unveils AI-enabled, stroke-preventing platform for doctors, raises $30M

The platform is designed to help doctors monitor patients for the early detection of atrial fibrillation, which is the most common cardiac arrhythmia.
Kardia Mobile app

AliveCor updates its mobile app to manage top risk factors for stroke

Both iOS and Android versions combine ECG, body weight and blood pressure to improve overall heart health and lower the risk of cardiovascular disease.
AliveCor

Small study shows AliveCor’s smartphone ECG is as good as standard Holter monitor

The study involved patients already wearing the standard Holter ambulatory event monitor with AliveCor's device being added to the mix.
AliveCor

AliveCor to launch remote monitoring trial for AFib with Columbia University

The 300-patient randomized trial will test the effect of remote monitoring on atrial fibrillation (AF) using AliveCor's Kardia Mobile device.
Kardia

AliveCor unveils Kardia Band for Apple Watch

Pending FDA's 510k clearance, the device provides caregivers the opportunity to take a more active role in helping their loved ones engage in their own care.